STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SNDX SYNDAX PHARMACEUTICALS INCORPORATED StockScouter® Report
6
StockScouter® Score
SYNDAX PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Moving average analysis for SNDX suggests strong price movement over the medium term. Positive
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
Concerns
- One or more analysts has modestly decreased quarterly earnings estimates for SNDX. Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
C
N/A
B